Track Record

Transactions

The team has completed over 300 transactions and engagements for its clients — valued at over $35 billion — as Bookrunner, Co-Manager, Lead Placement Agent, Co-Placement Agent or Advisor.

Featured Transactions

April 2025Alcyone TherapeuticsBrookline served as Exclusive Placement Agent for the Series F Convertible Preferred stock offering.
September 2025Sale to BiogenBiogen acquired Alcyone Therapeutics in 2025. Brookline served as Alcyone's financial advisor.
July 2026Neela TherapeuticsNeela Therapeutics was spun out of the acquisition and Brookline served as the Exclusive Placement Agent for a Convertible Note in 2026.

Selected Client Transactions

Adial Pharmaceuticals
Completed EngagementCapital Markets Advisor
December 2022
Syros Pharmaceuticals
Completed EngagementCapital Markets Advisor
November 2022
Imunon
Completed EngagementCapital Markets Advisor
November 2022
AGBA / TAG Holdings
$555,000,000
MergerCapital Markets Advisor to AGBA
November 2022
Hepion Pharmaceuticals
Completed EngagementCapital Markets Advisor
September 2022
Apexigen / Brookline Capital Acquisition Corp.
MergerBrookline Capital Holdings, LLC as Sponsor
August 2022
Apexigen / Brookline Capital Acquisition Corp.
$287,000,000
MergerCapital Markets Advisor
August 2022
Ainos
$3,300,000
Follow-OnCo-Manager
August 2022
Patheus Health
$4,575,000
Series A Convertible Preferred StockSole Placement Agent
August 2022
Circulogene
$2,820,000
Convertible NoteExclusive Placement Agent
June 2022
AnaBios
$15,000,000
Series C-2 Convertible Preferred StockFinancial Advisor
June 2022
Aquestive Therapeutics
$8,500,000
Registered DirectFinancial Advisor
June 2022
Novan
$15,000,000
Registered DirectFinancial Advisor
June 2022
Journey Medical Corporation
Completed EngagementCapital Markets Advisor
May 2022
Imunon
Completed EngagementCapital Markets Advisor
May 2022
Aquestive Therapeutics
Completed EngagementCapital Markets Advisor
April 2022
CNS Pharmaceuticals
Completed EngagementCapital Markets Advisor
April 2022
Scynexis
$45,000,000
Follow-OnCo-Manager
April 2022
Hepion Pharmaceuticals
Completed EngagementCapital Markets Advisor
March 2022
Scientific Industries
$3,000,000
PIPESole Placement Agent
March 2022
Relativity Acquisition Corporation
$143,750,000
IPOCo-Manager
February 2022
MEI Pharma
Completed EngagementCapital Markets Advisor
February 2022
RiverNorth Managed Duration Municipal Income Fund II
$165,000,000
IPOCo-Manager
February 2022
Cohen & Steers Real Estate & Opportunities Income Fund
$376,867,000
IPOCo-Manager
February 2022